SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-297165
Filing Date
2020-11-19
Accepted
2020-11-18 18:39:54
Documents
15
Period of Report
2020-11-18
Items
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d19559d8k.htm   iXBRL 8-K 34215
2 EX-99.1 d19559dex991.htm EX-99.1 12642
3 EX-99.2 d19559dex992.htm EX-99.2 15463
7 GRAPHIC g19559dsp6.jpg GRAPHIC 3440
  Complete submission text file 0001193125-20-297165.txt   202803

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bhc-20201118.xsd EX-101.SCH 2734
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20201118_lab.xml EX-101.LAB 18082
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20201118_pre.xml EX-101.PRE 11373
8 EXTRACTED XBRL INSTANCE DOCUMENT d19559d8k_htm.xml XML 3555
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 201326499
SIC: 2834 Pharmaceutical Preparations